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Clinics and pathology 
Disease 
Chronic lymphoproliferative leukemia (CLL). 
Epidemiology 
A 12p rearrangement is observed in about 1.4% CLL 
cases usually as part of a complex karyotype with 
multiple abnormalities, but about 7.7% of these are 
apparently sole cytogenetic abnormality. 
Prognosis 
12p rearrangements in CLL probably are early 
chromosome defects that are not associated with the 
classical DNA gains and losses known to be present in 
the majority of CLL. An atypical morphology and 
immunophenotype may be present in cases with 12p 
rearrangements; and frequently there is disease 
progression. Transformation of CLL to PLL has been 
observed in cases with a 12p abnormality. 
Cytogenetics 
Cytogenetics morphological 
Aberrations of 12p in CLL are often subtle addition to 
12p (n=15), followed by translocation (n=12), deletion 
(n=10), derivative (n=8), dicentric (n=3), inversion 
(n=2), and isochromosome (n=1). The breakpoint is 
commonly 12p13 in 31 cases (especially, in almost all 
del 12p cases), 12p12 in 7 cases, 12p11 in 10 cases, and 
12p10 in 1 case. 
The recurring 12p rearrangements in CLL are: 5 
translocations involving chromosomes 12 and 13, 
making it the most common recurring 12p 
translocation. In two of the five cases translocation, 
t(12;13) is the sole cytogenetic abnormality, but the 
breakpoints are different, t(12;13)(p13;q22) and 
t(12;13)(p11;q14). Translocation, t(12;13) has also  
been found in patients with chronic myelogenous 
leukemia (CML) in transformation, myelodysplastic 
syndrome (MDS), acute non lymphocytic leukemia 
(ANLL), B and T- acute lymphocytic leukemias 
(ALL). The t(12;13) is heterogeneous at the molecular 
level. A single case of ANLL has been reported with an 
ETV6-CDX2 fusion and ectopic expression of normal 
CDX2 but two other t(12;13) positive ANLL patients 
did not have CDX2 involvement. FISH analysis has 
suggested that the chromosome 13 breakpoints are 
different in myeloid and lymphoid disease. ETV6 
seems to be involved in some cases but not others.  
The other recurring translocation in CLL involved 
chromosomes 12 and 17 in 3 cases, 1 a translocation 
and 2 are derivative 12 resulting from a translocation 
between 12 and 17 chromosomes. This translocation is 
observed in patients with acute leukemia at diagnosis or 
relapse and who had a poor prognosis. 
Though, t(12;22)(p13;q11) is a consistent myeloid 
change there are at least 3  CLL cases with this 
translocation and one with ETV6 gene deletion. One 
case of CLL had a t(9;12)(q34;p11) as the sole 
abnormality, the breakpoint on chromosome 9 
coincided with that observed in 6 other cases with acute 
lymphoblastic leukemia (ALL), acute non lymphocytic 
leukemia (ANLL) and chronic myeloid leukemia 
(CML) while the 12 breakpoint 12p13 was different.  
Two different fusion breakpoints are described; ETV6 
exon 4 fused in frame to ABL exon 2 (Type A) and 
ETV6 exon 5 fused in frame to ABL exon 2 (Type B); 
ETV6 maintains the HLH domain and ABL the 
tyrosine kinase domain. Characterization of the 12p 
breakpoint of 12p rearrangements in lymphoid and 
myeloid malignancy in context to ETV expression may 
throw light on the lineage specificity of these 
rearrangements and their role in the malignancy. 
Other translocations of 12p observed in single CLL 
cases are der(12) t(12;18)(p13;q24), der(12) 
t(12;12)(p13;q13), der(12)t(1;12)(q11;p12),  






Atlas Genet Cytogenet Oncol Haematol. 2005; 9(4)  
 
328 




 dic(9;12)(p24;p13), dic(12;15)(p13;p11) and 
dic(3;12)(p21;p13). 
The inv(12) in 3 cases, is supernumerary in two cases 
+inv(12)(p13q24) and inv(12)(p13q13)x2, and 
?inv(12)(p11q23) in one case. 























































































































12p13=31, 12p12=7, 12p11=10, 12p10=1. 
add=15, der=8, del =10, t=12, inv=2, i=1, dic=3. 
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